De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

NCT05213676 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Congenital Diaphragmatic Hernia

Interventions

DRUG: Inhaled Nitric Oxide (iNO) use
OTHER: De-implementation of Inhaled Nitric Oxide (iNO) use

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]